10
Jul
2023
Category: Blog
26
Jun
2023
Bionest
Social Media Within the Healthcare Sector
Physicians and other healthcare providers have increasingly embraced social media to raise health awareness, combat misinformation and collaborate.
12
Jun
2023
Bionest
New Moves to Enhance Diversity in Clinical Trials
Despite efforts to increase diversity in clinical trials, many groups often remain significantly under-represented.
29
May
2023
Bionest
GLP-1 Agonists: The Next Pharma El Dorado? – Part 2
Will GLP-1 agents ultimately find success in NASH in addition to diabetes and obesity? We explore applications in liver disease in part two of our series.
15
May
2023
Bionest
GLP-1 Agonists: The Next Pharma El Dorado? – Part 1
Will GLP-1RAs ultimately succeed in the marketplace for obesity treatments, where other weight loss drugs have failed? In the first of a two-part blog series, we explore their use as a treatment of Type 2 diabetes & obesity.
1
May
2023
Bionest
Reactions to the Inflation Reduction Act and Drug Pricing
What impact will the Inflation Reduction Act have on pharmaceutical businesses, innovation and patients?
17
Apr
2023
Bionest
Evolving Gene Therapy Vectors for Greater Utility and Safety
Gene therapy has come a long way since it first emerged in the 1990s. Could new gene delivery strategies enable even wider applications?
3
Apr
2023
Bionest
The Growth of the Metaverse into Life Sciences and Health Care
Augmented reality, VR & other aspects of the metaverse are beginning to impact healthcare, from disability & elder care to hospital triage, surgical training, clinical trial monitoring, mental health & physical therapy.
20
Mar
2023
Bionest
FDA Finalizes Guidance on Multiple Endpoints in Clinical Trials
Assessing multiple endpoints in clinical trial results can prove challenging, prompting the FDA to provide new guidance for drug sponsors.
13
Mar
2023